Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position

References

• Global Health Observatory: Cancer mortality and morbidity [webpage on the Internet] Geneva World Health Organization 2011 Available from: http://www.who.int/gho/ncd/mortality_morbidity/cancer/en/index.html Accessed September 7, 2013
   Google Scholar
• Endicott JA Ling V The biochemistry of P-glycoprotein-mediated multidrug resistance Annu Rev Biochem 1989 58 137 171 2570548
   PubMed Web of Science ®Google Scholar
• Cole SP Bhardwaj G Gerlach JH Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 1992 258 5088 1650 1654 1360704
   PubMed Web of Science ®Google Scholar
• Doyle LA Yang W Abruzzo LV A multidrug resistance transporter from human MCF-7 breast cancer cells Proc Natl Acad Sci U S A 1998 95 26 15665 15670 9861027
   PubMed Web of Science ®Google Scholar
• Chang G Multidrug resistance ABC transporters FEBS Lett 2003 555 1 102 105 14630327
   PubMed Web of Science ®Google Scholar
• Natarajan K Xie Y Baer MR Ross DD Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance Biochem Pharmacol 2012 83 8 1084 1103 22248732
   PubMed Web of Science ®Google Scholar
• de Bruin M Miyake K Litman T Robey R Bates SE Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR Cancer Lett 1999 146 2 117 126 10656616
   PubMed Web of Science ®Google Scholar
• Rabindran SK He H Singh M Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C Cancer Res 1998 58 24 5850 5858 9865745
   PubMed Web of Science ®Google Scholar
• Allen JD van Loevezijn A Lakhai JM Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C Mol Cancer Ther 2002 1 6 417 425 12477054
   PubMed Web of Science ®Google Scholar
• Ahmed-Belkacem A Pozza A Muñoz-Martínez F Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2 Cancer Res 2005 65 11 4852 4860 15930306
   PubMed Web of Science ®Google Scholar
• Ahmed-Belkacem A Macalou S Borrelli F Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors J Med Chem 2007 50 8 1933 1938 17341062
   PubMed Web of Science ®Google Scholar
• Boumendjel A Macalou S Valdameri G Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation Curr Med Chem 2011 18 22 3387 3401 21728961
   PubMed Web of Science ®Google Scholar
• Sim HM Wu CP Ambudkar SV Go ML In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogs Biochem Pharmacol 2011 82 11 1562 1571 21855533
   PubMed Web of Science ®Google Scholar
• Valdameri G Pereira Rangel L Spatafora C Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein ACS Chem Biol 2012 7 2 322 330 22039929
   PubMed Web of Science ®Google Scholar
• Valdameri G Genoux-Bastide E Peres B Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein J Med Chem 2012 55 2 966 970 22165858
   PubMed Web of Science ®Google Scholar
• Tan KW Li Y Paxton JW Birch NP Scheepens A Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2) Food Chem 2013 138 4 2267 2274 23497885
   PubMed Web of Science ®Google Scholar
• Harvey AL Natural products in drug discovery Drug Discov Today 2008 13 19–20 894 901 18691670
   PubMed Web of Science ®Google Scholar
• Juvale K Pape VF Wiese M Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein Bioorg Med Chem 2012 20 1 346 355 22112540
   PubMed Web of Science ®Google Scholar
• Valdameri G Gauthier C Terreux R Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity J Med Chem 2012 55 7 3193 3200 22449016
   PubMed Web of Science ®Google Scholar
• Rangel LP Winter E Gauthier C New structure-activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity Drug Des Devel Ther 2013 7 1043 1052
   PubMed Web of Science ®Google Scholar
• Zhilina ZI Vodzinskii SV Andronati SA Synthesis and spectral characteristics of porphyrins with hetero and bicyclic meso substituents Ukrainskii Khimicheskii Zhurnal (Russian Edition) 1990 56 1084 1088
   Google Scholar
• Mielcke TR Mascarello A Filippi-Chiela E Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation Eur J Med Chem 2012 48 255 264 22209415
   PubMed Web of Science ®Google Scholar
• Chiaradia LD Mascarello A Purificação M Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA Bioorg Med Chem Lett 2008 18 23 6227 6230 18930396
   PubMed Web of Science ®Google Scholar
• Chiaradia LD Martins PG Cordeiro MN Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB) J Med Chem 2012 55 1 390 402 22136336
   PubMed Web of Science ®Google Scholar
• Halgren TA MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries J Comp Chem 1999 20 7 730 748
   PubMed Web of Science ®Google Scholar
• Cramer RDIII DePriest SA Patterson DE Hecht P The developing practice of comparative molecular field analysis Kubinyi H 3D QSAR in Drug Design: Theory, Methods and Applications Leiden ESCOM 1993
   Google Scholar
• Picard RR Cook RD Cross-validation of regression models J Am Stat Assoc 1984 79 387 575 583
   Web of Science ®Google Scholar
• Liu XL Tee HW Go ML Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein Bioorg Med Chem 2008 16 1 171 180 17964170
   PubMed Web of Science ®Google Scholar